Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -0.4x - -0.4x | -0.4x |
| Selected Fwd P/E Multiple | -0.3x - -0.3x | -0.3x |
| Fair Value | $0.049 - $0.054 | $0.052 |
| Upside | -19.1% - -10.6% | -14.9% |
| Benchmarks | - | Full Ticker |
| Charlotte's Web Holdings, Inc. | - | OTCPK:CWBH.F |
| Aurora Cannabis Inc. | - | NasdaqCM:ACB |
| 4Front Ventures Corp. | - | OTCPK:FFNT.F |
| Harmony Biosciences Holdings, Inc. | - | NasdaqGM:HRMY |
| Tarsus Pharmaceuticals, Inc. | - | NasdaqGS:TARS |
| Can B Corp. | - | OTCPK:CANB |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| CWBH.F | ACB | FFNT.F | HRMY | TARS | CANB | |||
| OTCPK:CWBH.F | NasdaqCM:ACB | OTCPK:FFNT.F | NasdaqGM:HRMY | NasdaqGS:TARS | OTCPK:CANB | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | 61.4% | NM- | NM- | ||
| Latest Twelve Months | -25.4% | 116.5% | 31.3% | 12.9% | 15.0% | -22.4% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -72.8% | -456.7% | -170.4% | -20.1% | -276.4% | -455.6% | ||
| Prior Fiscal Year | -37.7% | -354.3% | -19.8% | 22.1% | -778.9% | -223.2% | ||
| Latest Fiscal Year | -60.1% | -20.5% | -45.9% | 20.4% | -63.2% | -451.7% | ||
| Latest Twelve Months | -60.1% | 5.5% | -46.6% | 20.4% | -63.2% | -1282.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -1.8x | 5.7x | -13.3x | 5.8x | -15.1x | -3.2x | ||
| Price / LTM Sales | 0.3x | 1.0x | 0.0x | 2.3x | 11.0x | 4.5x | ||
| LTM P/E Ratio | -0.5x | 17.9x | -0.1x | 11.2x | -17.5x | -0.4x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -17.5x | -0.1x | 17.9x | |||||
| Historical LTM P/E Ratio | -3.1x | -0.7x | -0.1x | |||||
| Selected P/E Multiple | -0.4x | -0.4x | -0.4x | |||||
| (x) LTM Net Income | (13) | (13) | (13) | |||||
| (=) Equity Value | 5 | 5 | 6 | |||||
| (/) Shares Outstanding | 78.2 | 78.2 | 78.2 | |||||
| Implied Value Range | 0.07 | 0.07 | 0.07 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.07 | 0.07 | 0.07 | 0.06 | ||||
| Upside / (Downside) | 7.6% | 13.2% | 18.9% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CWBH.F | ACB | FFNT.F | HRMY | TARS | CANB | |
| Value of Common Equity | 13 | 319 | 2 | 1,636 | 2,018 | 5 | |
| (/) Shares Outstanding | 158.6 | 54.9 | 916.4 | 57.4 | 41.6 | 78.2 | |
| Implied Stock Price | 0.09 | 5.81 | 0.00 | 28.50 | 48.51 | 0.06 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.38 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.09 | 4.20 | 0.00 | 28.50 | 48.51 | 0.06 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.38 | 1.00 | 1.00 | 1.00 | 1.00 | |